A retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide ...
Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...
Glucagon-like peptide receptor agonists (GLP-1RAs) like Novo Nordisk’s semaglutide (Ozempic, Wegovy) and Eli Lilly’s ...
A study conducted using electronic health record data from a collective of U.S. health care systems found that most adults ...
Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.
Ascletis Pharma’s rapid-fire expansion into obesity drug development has passed another milestone. | Ascletis Pharma’s ...
Almost 2% of the U.S. population received prescriptions for the weight-loss and diabetes drugs semaglutide and tirzepatide in ...
A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and ...
A new study published JAMA Ophthalmology has brought attention to a series of vision problems observed in patients taking ...
"We are honored to be recognized as a top-performing company in the 2025 TSX Venture 50," said Shane Madden, CEO of Hydreight Technologies. "This achievement reflects our continued commitment to ...